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Background
Design of the artificial polyepitope immunogens capable
of eliciting high levels of the CD8+ CTL responses to the
most of contained epitopes is a promising approach in
creation of an efficient vaccine against HIV-1. When
designing such immunogens, it is necessary to provide
their processing to liberate the epitopes and present them
to the immune system. We have demonstrated that DNA
vaccine construct encoding poly-CTL-epitope immuno-
gen which contains N-terminal ubiquitin and residues
ensuring the proteasome processing of polyepitope con-
struct and transport liberated determinants through the
endoplasmic reticulum where they bind to MHC class I
molecules is most optimal for stimulating the maximal
CD8+ CTL responses. These results inspired us to create
PolyCTLDesigner software, intended for designing opti-
mal polyepitope antigens.
Methods
The PolyCTLDesigner program utilizes the models of Toes
et al. (2001) to predict the proteasomal/immunoproteas-
omal processing, the models of Peters et al. (2003) to pre-
dict the interactions between peptides and TAPs, and is
integrated with the TEpredict program which was devel-
oped earlier http://tepredict.sourceforge.net.
Results
PolyCTLDesigner allows the user to select the minimal set
of epitopes with the known (or predicted) specificity
towards various allelic variants of MHC class I molecules
covering the overall selected repertoire with a specified
redundancy. This program makes it possible to select the
flanking sequences for optimizing the binding of selected
peptides with TAP and joins the obtained peptide frag-
ments into a polyepitope construct to provide the libera-
tion of potential epitopes by proteasomal and/or
immunoproteasomal processing. More detailed informa-
tion about PolyCTLDesigner is available at http://tepre
dict.sourceforge.net/PolyCTLDesigner.html.
Conclusion
The developed software realizes the rational approach to
designing highly immunogenic poly-CTL-epitope vaccine
constructs and can be used for designing new candidate
polyepitope HIV-1 vaccines capable of eliciting high levels
of the T-cell-mediated immune responses to the most
selected epitopes.
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